The Radiochemistry and Molecular Imaging Probes (RMIP) Core functions at the intersection of the Cancer Center's laboratory research and clinical molecular imaging initiatives?including cancer biology, medicine, chemistry, physics, radiochemistry, pharmacology, and engineering, and is one of the largest manufacturing units at MSK in terms of the number of clinical and research products produced. The RMIP Core was established to provide investigators with radionuclides and to incorporate these radionuclides into radiolabeled diagnostic and/or therapeutic pharmaceuticals for both basic research investigations and patient formulations. The RMIP Core consists of 5 major elements working closely together to provide the following services: the Cyclotron Facility, the Small Molecule Radiochemistry Section, the Antibody Labeling Section, the Development and Clinical Translation Section and the Hyperpolarized Magnetic Resonance Section. MSK and the RMIP Core have an outstanding reputation for supporting clinical translation of both imaging and therapeutic agents. Specifically, with regard to the translation of radiopharmaceuticals, over the past 20 years, the RMIP Core has produced > 45 radiopharmaceuticals and molecular imaging agents for research clinical trials (imaging and therapy) in humans with radiolabeled antibodies, small molecules, nanoparticles and radiotherapeutics.
Romesser, Paul B; Pei, Xin; Shi, Weiji et al. (2018) Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients. Int J Radiat Oncol Biol Phys 100:59-67 |
Ankerst, Donna P; Straubinger, Johanna; Selig, Katharina et al. (2018) A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. Eur Urol 74:197-203 |
Scott, Jessica M; Nilsen, Tormod S; Gupta, Dipti et al. (2018) Exercise Therapy and Cardiovascular Toxicity in Cancer. Circulation 137:1176-1191 |
Routy, Bertrand; Le Chatelier, Emmanuelle; Derosa, Lisa et al. (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359:91-97 |
Hou, Xiaowei; Burstein, Shana R; Long, Stephen Barstow (2018) Structures reveal opening of the store-operated calcium channel Orai. Elife 7: |
Mori, Shoko; Navarrete-Dechent, Cristian; Petukhova, Tatyana A et al. (2018) Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centers. J Natl Compr Canc Netw 16:1209-1215 |
Pronier, Elodie; Cifani, Paolo; Merlinsky, Tiffany R et al. (2018) Targeting the CALR interactome in myeloproliferative neoplasms. JCI Insight 3: |
Munir, Annum; Banerjee, Ankan; Shuman, Stewart (2018) NAD+-dependent synthesis of a 5'-phospho-ADP-ribosylated RNA/DNA cap by RNA 2'-phosphotransferase Tpt1. Nucleic Acids Res 46:9617-9624 |
Valiente, Manuel; Ahluwalia, Manmeet S; Boire, Adrienne et al. (2018) The Evolving Landscape of Brain Metastasis. Trends Cancer 4:176-196 |
Geller, S; Marghoob, A A; Scope, A et al. (2018) Dermoscopy and the diagnosis of primary cutaneous B-cell lymphoma. J Eur Acad Dermatol Venereol 32:53-56 |
Showing the most recent 10 out of 8799 publications